Schedule 13G ownership disclosure

CELLECT BIOTECHNOLOGY LTD

Security class unavailable · CUSIP: 15116C102

Event date: 2018-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,636,360
Percent of class
2.7900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000056
Form type
SC 13G
Filer
Quoin Pharmaceuticals, Ltd.
CIK
CIK 1671502
Filed
Feb 01, 2018
Reporting period
Jan 29, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub